POLICY STATEMENT |
In recent years, umbilical cord blood, which contains a rich source of hematopoietic stem and progenitor cells, has been used successfully as an alternative allogeneic donor source to treat a variety of pediatric genetic, hematologic, immunologic, and oncologic disorders. Because there is diminished risk of graft-versus-host disease after transplantation of cord stem cells using matched related donors, the use of less-than-completely matched HLA cord blood stem cells may incur less risk of graft-versus-host disease than mismatched cells from either a related or unrelated "walking" donor, although this remains to be proven. Gene-therapy research involving modification of autologous cord blood stem cells for the treatment of childhood genetic disorders, although experimental at the present time, may prove to be of value. These scientific advances have resulted in the establishment of not-for-profit and for-profit cord bloodbanking programs for allogeneic and autologous cord blood transplantation. Many issues confront institutions that wish to establish or participate in such programs. Parents often seek information from their physicians about this new biotechnology option. This document is intended to provide information to guide physicians in responding to parents questions about cord blood donation and banking and the types and quality of cord blood banks. Provided also are recommendations about appropriate ethical and operational standards, including informed consent policies, financial disclosures, and conflict-of-interest policies for physicians, institutions, and organizations that operate or have a relationship with cord bloodbanking programs.
Key Words: cord blood stem cells hematology oncology
Abbreviations: FACTFoundation for the Accreditation of Cellular Therapy FDAUS Food and Drug Administration
The following policy statement has been revised:
This article has been cited by other articles:
![]() |
N. M Fisk and R. Atun Public-private partnership in cord blood banking BMJ, March 22, 2008; 336(7645): 642 - 644. [Full Text] [PDF] |
||||
![]() |
N. S. Fox, F. A. Chervenak, and L. B. McCullough Ethical Considerations in Umbilical Cord Blood Banking Obstet. Gynecol., January 1, 2008; 111(1): 178 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Smythe, S. Armitage, D. McDonald, D. Pamphilon, M. Guttridge, J. Brown, A. Green, C. Brown, R. M. Warwick, A. Lankester, et al. Directed Sibling Cord Blood Banking for Transplantation: The 10-Year Experience in the National Blood Service in England Stem Cells, August 1, 2007; 25(8): 2087 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. O'Keefe Great expectations: When should parents consider banking a newborn's cord blood? AAP News, January 1, 2007; 28(1): 17 - 17. [Full Text] |
||||
Read all P3Rs